Pioneering new therapies for cancer

LATEST NEWS

Upcoming Presentations of Gene Mutation and Clinical Response Data from Phase II Study of Pracinostat and Azacitidine in AML
Press Release | ASCO | EHA


MEI Pharma Reports Third Quarter Fiscal Year 2017 Results
Press Release | 10-Q


Presentation at Needham Healthcare Conference
Webcast | Slides


Results from Phase 2 Clinical Study of Pracinostat and Azacitidine in Acute Myeloid Leukemia
Press Release | ASH Presentation

 


MEI Pharma rides wave of interest in AML
View Interview